Kimia Biosciences Limited (BOM:530313)
33.56
+0.08 (0.24%)
At close: Nov 17, 2026
Kimia Biosciences Revenue
Kimia Biosciences had revenue of 268.08M INR in the quarter ending September 30, 2026, a decrease of -21.15%. This brings the company's total for the last twelve months to 1.04B, down -17.10% year-over-year. In the fiscal year ending March 31, 2026, Kimia Biosciences had annual revenue of 1.15B, down -3.39%. That makes Kimia Biosciences the 36,928th largest company in the world by revenue and 3,228th in India.
Revenue (ttm)
1.04B
Revenue Growth
-17.10%
P/S Ratio
1.52
Revenue / Employee
5.09M
Employees
205
Market Cap
1.59B
Revenue by Geography
- India 951.10M 83.0%
- outside India 194.99M 17.0%
Fiscal year ended Mar 31, 2026 See the full Kimia Biosciences breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.15B | -40.37M | -3.39% |
| Mar 31, 2025 | 1.19B | 140.44M | 13.39% |
| Mar 31, 2024 | 1.05B | -236.40M | -18.39% |
| Mar 31, 2023 | 1.29B | 36.15M | 2.89% |
| Mar 31, 2022 | 1.25B | -78.13M | -5.89% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.15B |
| Resonance Specialties | 1.14B |
| Smruthi Organics | 1.12B |
| Panchsheel Organics | 1.08B |
| Tyche Industries | 500.33M |
| Accretion Nutraveda | 489.95M |
| Himalaya Nutravedics India | 430.68M |
| Auro Laboratories | 407.90M |